Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556515 | PMC |
| http://dx.doi.org/10.3324/haematol.2019.230276 | DOI Listing |
Publication Analysis
Top Keywords
safety efficacy
4
efficacy brentuximab
4
brentuximab vedotin
4
vedotin treatment
4
treatment lymphoproliferative
4
lymphoproliferative disorders
4
disorders primary
4
primary immunodeficiencies
4
safety
1
brentuximab
1
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!